News
6d
MedPage Today on MSNGastric Cancer's Changing Trends in Incidence and Risk FactorsAlthough gastric cancer remains a major health issue both in the U.S. and worldwide, there has been a notable decline in ...
A young mother-of-one is given just 12 months to live after being diagnosed with aggressive stomach cancer—linitis plastica, ...
Georgia Gardiner from Leeds faced misdiagnosis for months. Later, she discovered she had rare stomach cancer. The cancer had ...
20hon MSN
Oesophageal cancer, often stealthy and lethal, ranks among the top ten cancers globally. Early symptoms are easily mistaken ...
When you spot the symptoms of stomach cancer, you can undergo the necessary tests, which can eventually help in early ...
1d
GlobalData on MSNAmgen and Zai Lab’s trial of gastric cancer therapy meets primary endpointAmgen and Zai Lab have reported that the Phase III FORTITUDE-101 trial, assessing bemarituzumab in combination with ...
Bonilla, MD, MSEd, discusses findings from the MATTERHORN trial in patients with resectable gastric or gastroesophageal junction adenocarcinoma.
Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...
The company formerly known as BeiGene announced that the Committee for Medicinal Products for Human Use (CHMP) has ...
There were no cases of HER2 positivity among patients with gliomas, sarcomas, small cell lung cancer, gastrointestinal stromal tumors, thyroid carcinoma, uterine sarcoma, thymic carcinoma, and Merkel ...
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results